Sanofi, GSK say their next-generation COVID-19 booster has 72% efficacy against omicronMarket Watch • 06/24/22
Investor views on GSK 'significantly swing towards positive' ahead of Haleon spin-offProactive Investors • 06/23/22
GSK plc (GSK) Management Presents at dbAcess Global Consumer Conference (Transcript)Seeking Alpha • 06/14/22
Ascential Digital Commerce and GSK Consumer Healthcare Announce Launch of Ascential Digital Commerce Connect at Cannes LionsBusiness Wire • 06/14/22
GSK plc (GSK) Goldman Sachs 43rd Annual Global Healthcare Conference (Transcript)Seeking Alpha • 06/13/22
Sanofi, GSK Covid Booster Triggers ‘Strong Immune Response' Against Multiple Variants Including OmicronForbes • 06/13/22
GSK seeks approval for respiratory vaccine after trials show 'meaningful efficacy'Proactive Investors • 06/10/22
GSK announces US FDA approval of PRIORIX for the prevention of measles, mumps and rubella in individuals 12 months of age and olderBusiness Wire • 06/06/22